Research

Barriers to Recovery in Post Concussive Syndrome

IRB Number: 12139

Institutional Review Board, Hospital for Special Surgery

November 19, 2012

The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.

For further information, see Understanding Clinical Trials.

Principal Investigator

Teena Shetty, MD

Co-Investigators

Niesha Voigt
Christine Villegas, MBS

Summary

A questionnaire will be sent out to Post Concussive Syndrome Patients to establish the correlation between the duration of quality rest and the recovery time following the concussion.

Inclusion/Exclusion Criteria

Inclusion:
 Past patients of Dr. Shetty that have had concussions.
 Male and female middle school, high school, and college athletes (ages 10-25).
Exclusion :
 If age is less than 10 or greater than 25
 Unable to provide informed consent
 Inability to complete the questionnaire

Contact Information

Teena Shetty, MD
ShettyT@hss.edu
212.774. 2138



Request an Appointment